John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$226M |
| 2 |
JPMorgan Chase
JPM
|
+$212M |
| 3 |
TSMC
TSM
|
+$204M |
| 4 |
Occidental Petroleum
OXY
|
+$194M |
| 5 |
Apple
AAPL
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$271M |
| 2 |
Microsoft
MSFT
|
+$267M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$255M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$226M |
| 5 |
Coca-Cola
KO
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.48% |
| 2 | Healthcare | 15.21% |
| 3 | Industrials | 10.23% |
| 4 | Consumer Discretionary | 10.15% |
| 5 | Financials | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LSI
376
DELISTED
Life Storage, Inc.
LSI
| $19.8M | 0.06% |
140,862
+111,069
| +373% | +$15M |
|
|
NSA
377
DELISTED
National Storage Affiliates Trust
NSA
| $19.7M | 0.06% |
313,738
-118,247
| -27% | -$7.28M |
|
|
CCXI
378
DELISTED
ChemoCentryx, Inc.
CCXI
| $19.6M | 0.06% |
781,994
-54,541
| -7% | -$1.53M |
|
379
Silicon Motion
SIMO
$8.76B
| $19.4M | 0.06% |
290,269
-177,843
| -38% | -$13.9M |
|
380
Descartes Systems
DSGX
$6.7B
| $19.4M | 0.06% |
264,627
+26,546
| +11% | +$1.91M |
|
|
ERF
381
DELISTED
Enerplus Corporation
ERF
| $19.4M | 0.06% |
1,525,797
-1,538,912
| -50% | -$18.7M |
|
382
Goldman Sachs
GS
$303B
| $19.4M | 0.06% |
+58,677
| New | +$20.7M |
|
383
Xylem
XYL
$26.5B
| $19.3M | 0.06% |
226,721
-39,104
| -15% | -$3.75M |
|
384
Teledyne Technologies
TDY
$29.5B
| $19.3M | 0.06% |
40,764
-1,473
| -3% | -$634K |
|
|
GAP
385
The Gap Inc
GAP
$7.13B
| $19.2M | 0.06% |
+1,364,842
| New | +$21.8M |
|
386
Murphy Oil
MUR
$5.36B
| $19.1M | 0.06% |
472,874
-417,582
| -47% | -$14.3M |
|
387
Hecla Mining
HL
$13.9B
| $19.1M | 0.06% |
2,906,278
-837,726
| -22% | -$4.85M |
|
388
Shake Shack
SHAK
$3.06B
| $19.1M | 0.06% |
281,160
+84,562
| +43% | +$5.82M |
|
389
Intrepid Potash
IPI
$525M
| $19.1M | 0.06% |
232,189
+225,749
| +3,505% | +$12.4M |
|
390
NXP Semiconductors
NXPI
$56.9B
| $18.9M | 0.06% |
102,237
+86,893
| +566% | +$17.1M |
|
391
PUT
Arbor Realty Trust
ABR
$968M
| $18.8M | 0.06% |
1,101,800
+428,000
| +64% | +$7.52M |
|
|
BHVN
392
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $18.7M | 0.06% |
157,363
-42,430
| -21% | -$5.29M |
|
393
Choice Hotels
CHH
$4.93B
| $18.5M | 0.05% |
130,598
-11,849
| -8% | -$1.71M |
|
|
MRTX
394
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $18.4M | 0.05% |
+224,277
| New | +$22.9M |
|
|
DAY
395
DELISTED
Dayforce
DAY
| $18.3M | 0.05% |
+267,803
| New | +$19.8M |
|
396
Integra LifeSciences
IART
$1.3B
| $18.1M | 0.05% |
+282,444
| New | +$18.6M |
|
397
Talos Energy
TALO
$2.92B
| $18.1M | 0.05% |
1,143,910
+794,048
| +227% | +$10.5M |
|
398
PagSeguro Digital
PAGS
$2.38B
| $18M | 0.05% |
898,444
+426,660
| +90% | +$7.94M |
|
399
Cboe Global Markets
CBOE
$31.4B
| $18M | 0.05% |
157,055
+100,644
| +178% | +$11.9M |
|
400
Editas Medicine
EDIT
$478M
| $17.9M | 0.05% |
942,092
-19,732
| -2% | -$367K |
|
Similar funds
John Overdeck's Q1 2022 Portfolio in Review
As of Q1 2022, John Overdeck held 4,846 positions worth $33.9B, down 28% from $46.8B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
John Overdeck withdrew a net $11.3B in Q1 2022, closing 2,304 positions and reducing 976 holdings. Its most notable exit was Pfizer, an estimated $271M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, John Overdeck opened a new position in Cisco worth $223M.
- John Overdeck's largest Q1 2022 buy was Cisco: 4,001,362 shares worth $223M.
- John Overdeck added most to JPMorgan Chase in Q1 2022, an estimated $212M increase.
- John Overdeck's biggest Q1 2022 reduction was Coca-Cola, cutting an estimated $225M.
- John Overdeck fully exited Pfizer in Q1 2022, selling an estimated $271M.
- John Overdeck's ten largest holdings make up 7.2% of its $33.9B portfolio in Q1 2022.
- John Overdeck opened 656 new positions and closed 2,304 in Q1 2022.
- John Overdeck's portfolio value fell 28% quarter-over-quarter to $33.9B.
Based on Two Sigma Investments's 13F filing for Q1 2022, filed 16 May 2022.